Your browser doesn't support javascript.
loading
Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody-Drug Conjugate for the Treatment of Cancer.
Toader, Dorin; Fessler, Shawn P; Collins, Scott D; Conlon, Patrick R; Bollu, Reddy; Catcott, Kalli C; Chin, Chen-Ni; Dirksen, Anouk; Du, Bingfan; Duvall, Jeremy R; Higgins, Stacy; Kozytska, Mariya V; Bellovoda, Kamela; Faircloth, Chelsey; Lee, David; Li, Fu; Qin, Liuliang; Routhier, Caitlin; Shaw, Pamela; Stevenson, Cheri A; Wang, Jason; Wongthida, Phonphimon; Ter-Ovanesyan, Elena; Ditty, Elizabeth; Bradley, Stephen P; Xu, Ling; Yin, Mao; Yurkovetskiy, Alexandr V; Mosher, Rebecca; Damelin, Marc; Lowinger, Timothy B.
Afiliação
  • Toader D; Mersana Therapeutics, Inc., 840 Memorial Drive, Cambridge, Massachusetts.
  • Fessler SP; Mersana Therapeutics, Inc., 840 Memorial Drive, Cambridge, Massachusetts.
  • Collins SD; Mersana Therapeutics, Inc., 840 Memorial Drive, Cambridge, Massachusetts.
  • Conlon PR; Mersana Therapeutics, Inc., 840 Memorial Drive, Cambridge, Massachusetts.
  • Bollu R; Mersana Therapeutics, Inc., 840 Memorial Drive, Cambridge, Massachusetts.
  • Catcott KC; Mersana Therapeutics, Inc., 840 Memorial Drive, Cambridge, Massachusetts.
  • Chin CN; Mersana Therapeutics, Inc., 840 Memorial Drive, Cambridge, Massachusetts.
  • Dirksen A; Mersana Therapeutics, Inc., 840 Memorial Drive, Cambridge, Massachusetts.
  • Du B; Mersana Therapeutics, Inc., 840 Memorial Drive, Cambridge, Massachusetts.
  • Duvall JR; Mersana Therapeutics, Inc., 840 Memorial Drive, Cambridge, Massachusetts.
  • Higgins S; Mersana Therapeutics, Inc., 840 Memorial Drive, Cambridge, Massachusetts.
  • Kozytska MV; Mersana Therapeutics, Inc., 840 Memorial Drive, Cambridge, Massachusetts.
  • Bellovoda K; Mersana Therapeutics, Inc., 840 Memorial Drive, Cambridge, Massachusetts.
  • Faircloth C; Mersana Therapeutics, Inc., 840 Memorial Drive, Cambridge, Massachusetts.
  • Lee D; Mersana Therapeutics, Inc., 840 Memorial Drive, Cambridge, Massachusetts.
  • Li F; Pheon Therapeutics, Cambridge MA 02139.
  • Qin L; Mersana Therapeutics, Inc., 840 Memorial Drive, Cambridge, Massachusetts.
  • Routhier C; Mersana Therapeutics, Inc., 840 Memorial Drive, Cambridge, Massachusetts.
  • Shaw P; Mersana Therapeutics, Inc., 840 Memorial Drive, Cambridge, Massachusetts.
  • Stevenson CA; Mersana Therapeutics, Inc., 840 Memorial Drive, Cambridge, Massachusetts.
  • Wang J; Mersana Therapeutics, Inc., 840 Memorial Drive, Cambridge, Massachusetts.
  • Wongthida P; Mersana Therapeutics, Inc., 840 Memorial Drive, Cambridge, Massachusetts.
  • Ter-Ovanesyan E; Mersana Therapeutics, Inc., 840 Memorial Drive, Cambridge, Massachusetts.
  • Ditty E; Mersana Therapeutics, Inc., 840 Memorial Drive, Cambridge, Massachusetts.
  • Bradley SP; Mersana Therapeutics, Inc., 840 Memorial Drive, Cambridge, Massachusetts.
  • Xu L; Mersana Therapeutics, Inc., 840 Memorial Drive, Cambridge, Massachusetts.
  • Yin M; Mersana Therapeutics, Inc., 840 Memorial Drive, Cambridge, Massachusetts.
  • Yurkovetskiy AV; Mersana Therapeutics, Inc., 840 Memorial Drive, Cambridge, Massachusetts.
  • Mosher R; Mersana Therapeutics, Inc., 840 Memorial Drive, Cambridge, Massachusetts.
  • Damelin M; Mersana Therapeutics, Inc., 840 Memorial Drive, Cambridge, Massachusetts.
  • Lowinger TB; Mersana Therapeutics, Inc., 840 Memorial Drive, Cambridge, Massachusetts.
Mol Cancer Ther ; 22(9): 999-1012, 2023 09 05.
Article em En | MEDLINE | ID: mdl-37294948

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Imunoconjugados / Antineoplásicos Limite: Female / Humans Idioma: En Revista: Mol Cancer Ther Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Imunoconjugados / Antineoplásicos Limite: Female / Humans Idioma: En Revista: Mol Cancer Ther Ano de publicação: 2023 Tipo de documento: Article